Effects of perioperative early enteral nutrition and glycemic control in patients with diabetes mellitus complicated with gastric cancer

Figure 1 Comparative analysis of glycemic parameters. ^aP < 0.05 vs before treatment; ^bP < 0.01 vs before treatment; ^cP < 0.05 vs the control group. A: Pre-treatment and post-treatment fasting blood glucose in the control group and the research group; B: Pre-treatment and post-treatment 2-hour postprandial blood glucose in the control group and the research group; C: Pre-treatment and post-treatment glycated hemoglobin in the control group and the research group. FBG: Fasting blood glucose; 2h-PBG: 2-hour postprandial blood glucose; HbA1c: Glycated hemoglobin.

Figure 2 Comparative analysis of nutritional indicators. ^aP < 0.05 vs before treatment; ^bP < 0.01 vs before treatment; ^cP < 0.05 vs the control group. A: Pre-treatment and post-treatment prealbumin in the control group and the research group; B: Pre-treatment and post-treatment transferrin in the control group and the research group; C: Pre-treatment and post-treatment total protein in the control group and the research group. PA: Prealbumin; TRF: Transferrin; TP: Total protein.

Figure 3 Comparative analysis of humoral immunity indicators. ^aP < 0.05 vs before treatment; ^bP < 0.01 vs before treatment; ^cP < 0.05 vs the control group. A: Pre-treatment and post-treatment immunoglobulin (Ig) A in the control group and the research group; B: Pre-treatment and post-treatment IgM in the control group and the research group; C: Pre-treatment and post-treatment IgG in the control group and the research group. Ig: Immunoglobulin.

Figure 4 Comparative analysis of recovery indicators. ^bP < 0.01. A: Wound healing time in the control group and the research group; B: Time to first passage of flatus in the control group and the research group; C: Length of hospital stay in the control group and the research group.